Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

MSR1 repeats modulate gene expression and affect risk of breast and prostate cancer.

Rose AM, Krishan A, Chakarova CF, Moya L, Chambers SK, Hollands M, Illingworth JC, Williams SMG, McCabe HE, Shah AZ, Palmer CNA, Chakravarti A, Berg JN, Batra J, Bhattacharya SS.

Ann Oncol. 2018 May 1;29(5):1292-1303. doi: 10.1093/annonc/mdy082.

PMID:
29509840
2.

A systematic review of the diagnostic accuracy of automated tests for cognitive impairment.

Aslam RW, Bates V, Dundar Y, Hounsome J, Richardson M, Krishan A, Dickson R, Boland A, Fisher J, Robinson L, Sikdar S.

Int J Geriatr Psychiatry. 2018 Apr;33(4):561-575. doi: 10.1002/gps.4852. Epub 2018 Jan 22. Review.

3.

Guidelines for the Content of Statistical Analysis Plans in Clinical Trials.

Gamble C, Krishan A, Stocken D, Lewis S, Juszczak E, Doré C, Williamson PR, Altman DG, Montgomery A, Lim P, Berlin J, Senn S, Day S, Barbachano Y, Loder E.

JAMA. 2017 Dec 19;318(23):2337-2343. doi: 10.1001/jama.2017.18556.

PMID:
29260229
4.

Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Fleeman N, Bagust A, Boland A, Beale S, Richardson M, Krishan A, Stainthorpe A, Abdulla A, Kotas E, Banks L, Payne M.

Pharmacoeconomics. 2017 Oct;35(10):1035-1046. doi: 10.1007/s40273-017-0504-6. Review.

PMID:
28316007
5.

Automated tests for diagnosing and monitoring cognitive impairment: a diagnostic accuracy review.

Aslam RW, Bates V, Dundar Y, Hounsome J, Richardson M, Krishan A, Dickson R, Boland A, Kotas E, Fisher J, Sikdar S, Robinson L.

Health Technol Assess. 2016 Oct;20(77):1-74. Review.

6.

Perioperative elafin for ischaemia-reperfusion injury during coronary artery bypass graft surgery: a randomised-controlled trial.

Alam SR, Lewis SC, Zamvar V, Pessotto R, Dweck MR, Krishan A, Goodman K, Oatey K, Harkess R, Milne L, Thomas S, Mills NM, Moore C, Semple S, Wiedow O, Stirrat C, Mirsadraee S, Newby DE, Henriksen PA.

Heart. 2015 Oct;101(20):1639-45. doi: 10.1136/heartjnl-2015-307745. Epub 2015 Aug 26.

7.

Mixed methods feasibility study for a trial of blood pressure telemonitoring for people who have had stroke/transient ischaemic attack (TIA).

Hanley J, Fairbrother P, Krishan A, McCloughan L, Padfield P, Paterson M, Pinnock H, Sheikh A, Sudlow C, Todd A, McKinstry B.

Trials. 2015 Mar 25;16:117. doi: 10.1186/s13063-015-0628-y.

8.

Increased Hospital-Based Physical Rehabilitation and Information Provision After Intensive Care Unit Discharge: The RECOVER Randomized Clinical Trial.

Walsh TS, Salisbury LG, Merriweather JL, Boyd JA, Griffith DM, Huby G, Kean S, Mackenzie SJ, Krishan A, Lewis SC, Murray GD, Forbes JF, Smith J, Rattray JE, Hull AM, Ramsay P; RECOVER Investigators.

JAMA Intern Med. 2015 Jun;175(6):901-10. doi: 10.1001/jamainternmed.2015.0822.

PMID:
25867659
9.

Cancer treatment-related neuropathic pain: proof of concept study with menthol--a TRPM8 agonist.

Fallon MT, Storey DJ, Krishan A, Weir CJ, Mitchell R, Fleetwood-Walker SM, Scott AC, Colvin LA.

Support Care Cancer. 2015 Sep;23(9):2769-77. doi: 10.1007/s00520-015-2642-8. Epub 2015 Feb 15.

10.

Telemonitoring for chronic obstructive pulmonary disease: a cost and cost-utility analysis of a randomised controlled trial.

Stoddart A, van der Pol M, Pinnock H, Hanley J, McCloughan L, Todd A, Krishan A, McKinstry B.

J Telemed Telecare. 2015 Mar;21(2):108-18. doi: 10.1177/1357633X14566574. Epub 2015 Jan 13.

PMID:
25586810
11.

Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function.

Szalontay L, Schally AV, Popovics P, Vidaurre I, Krishan A, Zarandi M, Cai RZ, Klukovits A, Block NL, Rick FG.

Cell Cycle. 2014;13(17):2790-7. doi: 10.4161/15384101.2015.945879.

12.

Computed tomography angiography or magnetic resonance angiography for detection of intracranial vascular malformations in patients with intracerebral haemorrhage.

Josephson CB, White PM, Krishan A, Al-Shahi Salman R.

Cochrane Database Syst Rev. 2014 Sep 1;(9):CD009372. doi: 10.1002/14651858.CD009372.pub2. Review.

PMID:
25177839
13.

Intrathecal fentanyl as an adjuvant to 0.75% isobaric ropivacaine for infraumbilical surgery under subarachnoid block: A prospective study.

Gupta K, Singh S, Sharma D, Gupta PK, Krishan A, Pandey MN.

Saudi J Anaesth. 2014 Jan;8(1):64-8. doi: 10.4103/1658-354X.125939.

14.

Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial.

Pinnock H, Hanley J, McCloughan L, Todd A, Krishan A, Lewis S, Stoddart A, van der Pol M, MacNee W, Sheikh A, Pagliari C, McKinstry B.

BMJ. 2013 Oct 17;347:f6070. doi: 10.1136/bmj.f6070.

15.

Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial.

Walsh TS, Boyd JA, Watson D, Hope D, Lewis S, Krishan A, Forbes JF, Ramsay P, Pearse R, Wallis C, Cairns C, Cole S, Wyncoll D; RELIEVE Investigators.

Crit Care Med. 2013 Oct;41(10):2354-63. doi: 10.1097/CCM.0b013e318291cce4.

PMID:
23939351
16.

Telemonitoring-based service redesign for the management of uncontrolled hypertension (HITS): cost and cost-effectiveness analysis of a randomised controlled trial.

Stoddart A, Hanley J, Wild S, Pagliari C, Paterson M, Lewis S, Sheikh A, Krishan A, Padfield P, McKinstry B.

BMJ Open. 2013 May 28;3(5). pii: e002681. doi: 10.1136/bmjopen-2013-002681.

17.

Telemonitoring based service redesign for the management of uncontrolled hypertension: multicentre randomised controlled trial.

McKinstry B, Hanley J, Wild S, Pagliari C, Paterson M, Lewis S, Sheikh A, Krishan A, Stoddart A, Padfield P.

BMJ. 2013 May 24;346:f3030. doi: 10.1136/bmj.f3030.

18.

Chameleon dyes which change their color on excitation.

Krishan A.

Cytometry A. 2013 May;83(5):422-3. doi: 10.1002/cyto.a.22279. No abstract available.

19.

Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.

Rick FG, Abi-Chaker A, Szalontay L, Perez R, Jaszberenyi M, Jayakumar AR, Shamaladevi N, Szepeshazi K, Vidaurre I, Halmos G, Krishan A, Block NL, Schally AV.

Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2617-22. doi: 10.1073/pnas.1222355110. Epub 2013 Jan 28.

20.

Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia.

Rick FG, Schally AV, Block NL, Abi-Chaker A, Krishan A, Szalontay L.

Prostate. 2013 Jun;73(8):873-83. doi: 10.1002/pros.22633. Epub 2012 Dec 31.

PMID:
23280565
21.

Premedication with clonidine versus fentanyl for intraoperative hemodynamic stability and recovery outcome during laparoscopic cholecystectomy under general anesthesia.

Gupta K, Lakhanpal M, Gupta PK, Krishan A, Rastogi B, Tiwari V.

Anesth Essays Res. 2013 Jan-Apr;7(1):29-33. doi: 10.4103/0259-1162.113984.

22.

GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer.

Rick FG, Seitz S, Schally AV, Szalontay L, Krishan A, Datz C, Stadlmayr A, Buchholz S, Block NL, Hohla F.

Cell Cycle. 2012 Nov 15;11(22):4203-10. doi: 10.4161/cc.22498. Epub 2012 Oct 24.

23.

Role of multidetector computed tomography in the diagnosis and management of patients attending the rapid access chest pain clinic, The Scottish computed tomography of the heart (SCOT-HEART) trial: study protocol for randomized controlled trial.

Newby DE, Williams MC, Flapan AD, Forbes JF, Hargreaves AD, Leslie SJ, Lewis SC, McKillop G, McLean S, Reid JH, Sprat JC, Uren NG, van Beek EJ, Boon NA, Clark L, Craig P, Flather MD, McCormack C, Roditi G, Timmis AD, Krishan A, Donaldson G, Fotheringham M, Hall FJ, Neary P, Cram L, Perkins S, Taylor F, Eteiba H, Rae AP, Robb K, Barrie D, Bissett K, Dawson A, Dundas S, Fogarty Y, Ramkumar PG, Houston GJ, Letham D, O'Neill L, Pringle SD, Ritchie V, Sudarshan T, Weir-McCall J, Cormack A, Findlay IN, Hood S, Murphy C, Peat E, Allen B, Baird A, Bertram D, Brian D, Cowan A, Cruden NL, Dweck MR, Flint L, Fyfe S, Keanie C, MacGillivray TJ, Maclachlan DS, MacLeod M, Mirsadraee S, Morrison A, Mills NL, Minns FC, Phillips A, Queripel LJ, Weir NW, Bett F, Divers F, Fairley K, Jacob AJ, Keegan E, White T, Gemmill J, Henry M, McGowan J, Dinnel L, Francis CM, Sandeman D, Yerramasu A, Berry C, Boylan H, Brown A, Duffy K, Frood A, Johnstone J, Lanaghan K, MacDuff R, MacLeod M, McGlynn D, McMillan N, Murdoch L, Noble C, Paterson V, Steedman T, Tzemos N.

Trials. 2012 Oct 4;13:184. doi: 10.1186/1745-6215-13-184.

24.

Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers.

Rick FG, Buchholz S, Schally AV, Szalontay L, Krishan A, Datz C, Stadlmayr A, Aigner E, Perez R, Seitz S, Block NL, Hohla F.

Cell Cycle. 2012 Jul 1;11(13):2518-25. doi: 10.4161/cc.20900. Epub 2012 Jul 1.

25.

Assessment of the subglottic region by ultrasonography for estimation of appropriate size endotracheal tube: A clinical prospective study.

Gupta K, Gupta PK, Rastogi B, Krishan A, Jain M, Garg G.

Anesth Essays Res. 2012 Jul-Dec;6(2):157-60. doi: 10.4103/0259-1162.108298.

26.

The prophylactic role of tranexamic acid to reduce blood loss during radical surgery: A prospective study.

Gupta K, Rastogi B, Krishan A, Gupta A, Singh VP, Agarwal S.

Anesth Essays Res. 2012 Jan-Jun;6(1):70-3. doi: 10.4103/0259-1162.103378.

27.

Click-iT proliferation assay with improved DNA histograms.

Krishan A, Hamelik RM.

Curr Protoc Cytom. 2010 Apr;Chapter 7:Unit7.36. doi: 10.1002/0471142956.cy0736s52.

PMID:
20373496
28.

Targeted cytotoxic somatostatin analog AN-162 inhibits growth of human colon carcinomas and increases sensitivity of doxorubicin resistant murine leukemia cells.

Hohla F, Buchholz S, Schally AV, Krishan A, Rick FG, Szalontay L, Papadia A, Halmos G, Koster F, Aigner E, Datz C, Seitz S.

Cancer Lett. 2010 Aug 1;294(1):35-42. doi: 10.1016/j.canlet.2010.01.018. Epub 2010 Feb 13.

PMID:
20156671
29.

Electronic volume, aldehyde dehydrogenase, and stem cell marker expression in cells from human peripheral blood apheresis samples.

Sharma S, Shariatmadar S, Krishan A.

Cytometry B Clin Cytom. 2010 Mar;78(2):123-9. doi: 10.1002/cyto.b.20505.

30.

Intramedullary nailing and plate osteosynthesis for fractures of the distal metaphyseal tibia and fibula.

Krishan A, Peshin C, Singh D.

J Orthop Surg (Hong Kong). 2009 Dec;17(3):317-20.

PMID:
20065372
31.

ALDH(+)/CD44(+)/CD24(-) expression in cells from body cavity fluids.

Krishan A, Sharma D, Sharma S, Hamelik RM, Ganjei-Azar P, Nadji M.

Cytometry B Clin Cytom. 2010 May;78(3):176-82. doi: 10.1002/cyto.b.20509.

32.

Flow immunocytochemistry of marker expression in cells from body cavity fluids.

Krishan A, Ganjei-Azar P, Hamelik R, Sharma D, Reis I, Nadji M.

Cytometry A. 2010 Feb;77(2):132-43. doi: 10.1002/cyto.a.20824.

33.

GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cells.

Hohla F, Buchholz S, Schally AV, Seitz S, Rick FG, Szalontay L, Varga JL, Zarandi M, Halmos G, Vidaurre I, Krishan A, Kurtoglu M, Chandna S, Aigner E, Datz C.

Cell Cycle. 2009 Oct 1;8(19):3149-56. Epub 2009 Oct 3.

PMID:
19755849
34.

Triple-negative breast cancers express receptors for luteinizing hormone-releasing hormone (LHRH) and respond to LHRH antagonist cetrorelix with growth inhibition.

Buchholz S, Seitz S, Schally AV, Engel JB, Rick FG, Szalontay L, Hohla F, Krishan A, Papadia A, Gaiser T, Brockhoff G, Ortmann O, Diedrich K, Köster F.

Int J Oncol. 2009 Oct;35(4):789-96.

PMID:
19724914
35.

Click-iT assay with improved DNA distribution histograms.

Hamelik RM, Krishan A.

Cytometry A. 2009 Oct;75(10):862-5. doi: 10.1002/cyto.a.20780.

36.

Application of anti-ssDNA monoclonal antibody to study exogenous and apoptosis-associated DNA damage.

Frankfurt O, Krishan A.

Cytometry A. 2008 Dec;73A(12):1114-5. doi: 10.1002/cyto.a.20629. No abstract available.

37.

Hormone receptor-related gene polymorphisms and prostate cancer risk in North Indian population.

Onsory K, Sobti RC, Al-Badran AI, Watanabe M, Shiraishi T, Krishan A, Mohan H, Kaur P.

Mol Cell Biochem. 2008 Jul;314(1-2):25-35. doi: 10.1007/s11010-008-9761-1. Epub 2008 May 16.

PMID:
18483761
38.

Electronic volume of CD34 positive cells from peripheral blood apheresis samples.

Shariatmadar S, Sharma S, Cabana R, Powell S, Ruiz P, Krishan A.

Cytometry B Clin Cytom. 2008 May;74(3):182-8. doi: 10.1002/cyto.b.20399.

39.

Cellular volume and marker expression in human peripheral blood apheresis stem cells.

Sharma S, Cabana R, Shariatmadar S, Krishan A.

Cytometry A. 2008 Feb;73(2):160-7. doi: 10.1002/cyto.a.20524.

41.

Are increased tumor aneuploidy and heightened cell proliferation along with heterogeneity associated with patient outcome for carcinomas of the uterine cervix? A combined analysis of subjects treated in RTOG 9001 and a single-institution trial.

Wolfson AH, Winter K, Crook W, Krishan A, Grigsby PW, Markoe AM, Morris M, Gaffney DK, Eifel PJ, Lucci JA 3rd.

Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):111-7. Epub 2007 Oct 24.

PMID:
17919835
42.

The minimal instrumentation requirements for Hoechst side population analysis: stem cell analysis on low-cost flow cytometry platforms.

Cabana R, Frolova EG, Kapoor V, Thomas RA, Krishan A, Telford WG.

Stem Cells. 2006 Nov;24(11):2573-81. Epub 2006 Aug 3.

43.

Detection of tumor cells in body cavity fluids by flow cytometric and immunocytochemical analysis.

Krishan A, Ganjei-Azar P, Jorda M, Hamelik RM, Reis IM, Nadji M.

Diagn Cytopathol. 2006 Aug;34(8):528-41.

PMID:
16850481
44.

CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in North Indian population.

Sobti RC, Onsory K, Al-Badran AI, Kaur P, Watanabe M, Krishan A, Mohan H.

DNA Cell Biol. 2006 May;25(5):287-94.

PMID:
16716118
45.

Androgen & vitamin D nuclear receptor expression in archival breast tumour samples.

Satish Rao BS, Krishnanand BR, Krishan A.

Indian J Med Res. 2006 Jan;123(1):73-82.

PMID:
16567872
46.

Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells".

Lampidis TJ, Kurtoglu M, Maher JC, Liu H, Krishan A, Sheft V, Szymanski S, Fokt I, Rudnicki WR, Ginalski K, Lesyng B, Priebe W.

Cancer Chemother Pharmacol. 2006 Dec;58(6):725-34. Epub 2006 Mar 23.

PMID:
16555088
47.

Influence of number of CAG repeats on local control in the RTOG 86-10 protocol.

Abdel-Wahab M, Berkey BA, Krishan A, O'Brien T, Hammond E, Roach M 3rd, Lawton C, Pilepich M, Markoe A, Pollack A.

Am J Clin Oncol. 2006 Feb;29(1):14-20.

PMID:
16462497
48.

DAPI fluorescence in nuclei isolated from tumors.

Krishan A, Dandekar PD.

J Histochem Cytochem. 2005 Aug;53(8):1033-6.

PMID:
16055751
49.

Flow cytometric monitoring of fluorescent drug retention and efflux.

Krishan A, Hamelik RM.

Methods Mol Med. 2005;111:149-66.

PMID:
15911978
50.

DNA index, genome size, and electronic nuclear volume of vertebrates from the Miami Metro Zoo.

Krishan A, Dandekar P, Nathan N, Hamelik R, Miller C, Shaw J.

Cytometry A. 2005 May;65(1):26-34.

Supplemental Content

Loading ...
Support Center